Is ATAI or AVBP more undervalued in 2026?

CirclFi compares AtaiBeckley Inc. (ATAI) and ArriVent BioPharma, Inc. (AVBP) using 13 institutional-grade valuation models. ATAI has a Quality of Company score of 4.9/10 while AVBP scores 3.6/10.

Which is a better buy — ATAI or AVBP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ATAI and AVBP valuations compare?

ATAI at $4.53 and AVBP at $30.27 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ATAI vs AVBP Valuation Comparison 2026 — Intrinsic Value Analysis

ATAI

Pharmaceutical Preparations

AtaiBeckley Inc.

Quality

4.9

out of 10

Value Trap

—

Price

$4.53

Last close

Models

5/13

Active

AVBP

Pharmaceutical Preparations

ArriVent BioPharma, Inc.

Quality

3.6

out of 10

Value Trap

SAFE

Price

$30.27

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ATAI Fair Value	ATAI Upside	AVBP Fair Value	AVBP Upside
Bayesian DCF	Intrinsic	$1.01	-77.6%	$7.91	-73.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$2.35	-48.2%	$0.59	-98.0%
Dynamic NAV	Asset-Based	$0.41	-90.9%	$6.38	-78.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ATAI vs AVBP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ATAI vs AVBP — Which Stock Is More Undervalued?

ATAI scores higher with a 4.9/10 quality rating vs AVBP's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing AtaiBeckley Inc. (ATAI) and ArriVent BioPharma, Inc. (AVBP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ATAI currently trades at $4.53 with a QOC of 4.9/10, while AVBP trades at $30.27 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).